-
Sara R. Collins
Senior Scholar, Vice President, Health Care Coverage and Access & Tracking Health System Performance, The Commonwealth Fund
-
Karen Davis
Professor Emerita in the Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health
-
Sarah Klein
Consulting Writer and Editor
Showing 163 - 171 of 4218 Results
Grant
The Role of Financial Incentives in Biosimilar Uptake in Medicare: Evidence from the 340B Program- Grantee Organization: Joan and Sanford I. Weill Medical College of Cornell University
- Principal Investigator: Amelia Bond, Ph.D., M.H.S.
blog / Jan 19, 2022
Medicare’s Decision to Cover the Alzheimer’s Drug Aduhelm: What Will It Mean for Patients and the Program?blog / May 31, 2022
Supreme Court Could Strip Protections from Millions of Federal Program BeneficiariesIssue Briefs / Aug 07, 2014
Caring for High-Need, High-Cost Patients: What Makes for a Successful Care Management Program?blog / Oct 28, 2019
Indiana’s Medicaid Work-Requirement Program Is Expected to Cause Tens of Thousands to Lose Coverageblog / Mar 15, 2018
340B Drug Discount Program: Why More Transparency Will Help Low-Income Communities